City

Chicago (1)

Los Angeles (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Jonsson Comprehensive Cancer Center (1)

University of Chicago (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (2)

hypofractionated radiation therapy (1)

intensity-modulated radiation therapy (1)

pembrolizumab (1)

pharmacogenomic study (1)

therapeutic conventional surgery (1)

Study Documents

Intervention Type

other (2)

biological (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

pleural epithelioid mesothelioma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting

Biphasic Mesothelioma
+9 more

Pembrolizumab
+2 more

Chicago, Illinois

University of Chicago

Apr 18, 2022

Pleural Epithelioid Mesothelioma, Pleural Malignant Mesothelioma Trial in Los Angeles (radiation, other, procedure)

Terminated

Has Results

Pleural Epithelioid Mesothelioma
Pleural Malignant Mesothelioma

Hypofractionated Radiation Therapy
+3 more

Los Angeles, California

UCLA / Jonsson Comprehensive Cancer Center

Jul 22, 2020